News

Scientists have found a lipid transporter crucial to regulating the cells that make myelin, the nerve-protecting sheath.

There’s a strong link between psychedelic drugs and our vision. Trippy details, unexpected saccades and pupil dilation are all linked to taking compounds like LSD, magic mushrooms and DMT. But a new case report may be the first detailed documentation of a psychedelic temporarily reversing a diagnosis of color blindness.

A combination of glycine and N-acetylcysteine improved or reversed age-associated cognitive decline in old mice and improved multiple associated defects in the aging brain.

Research into how the brain responds to seizures could facilitate the development of treatments for patients who don’t respond to existing options.

Discovery may help explain why a drug used to treat the disease increases life expectancy – and whether it also improves brain function.

New research has linked drinking coffee and tea to increased macular retinal nerve fibre layer thickness – which could be an indicator of our brain health.

New findings in color vision research imply that humans can perceive a greater range of blue tones than monkeys do.

Similar to humans, chimpanzees combine vocalizations into larger communicatively meaningful structures. Researchers suggest that this ability might be evolutionarily more ancient than previously thought.

Researchers report on the first-of-its-kind fetal procedure to fix a potentially deadly vascular malformation in the brain, avoiding heart failure and brain injury after birth.

Pharmaceutical giant Eli Lilly and Company has announced encouraging data from its Phase 3 study of Alzheimer’s drug donanemab, a monoclonal antibody that Lilly claims slowed trial participants’ cognitive decline by 35%.